Viewing StudyNCT03705403



Ignite Creation Date: 2024-05-06 @ 12:14 PM
Last Modification Date: 2024-10-26 @ 12:56 PM
Study NCT ID: NCT03705403
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-17
First Post: 2018-06-27

Brief Title: IMMUNOtherapy and Stereotactic ABlative Radiotherapy IMMUNOSABR a Phase II Study
Sponsor: Maastricht University Medical Center
Organization: Maastricht University Medical Center

Conditions & Keywords Data

Conditions:
Name
Metastatic Disease
NSCLC Stage IV
Keywords: